Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics

Lipid nanoparticles (LNPs) have emerged as a powerful non-viral carrier for drug delivery. With the prevalence of respiratory diseases, particularly highlighted by the current COVID-19 pandemic, investigations into applying LNPs to deliver inhaled therapeutics directly to the lungs are underway. The...

Full description

Bibliographic Details
Published in:	Biomedicines
Main Authors:	Ellenmae W. X. Leong, Ruowen Ge
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Subjects:	lipid nanoparticles (LNPs) inhalation drug delivery lung respiratory diseases
Online Access:	https://www.mdpi.com/2227-9059/10/9/2179

Similar Items

Intranasal and Pulmonary Lipid Nanoparticles for Gene Delivery: Turning Challenges into Opportunities
by: Tayyar Y, et al.
Published: (2025-06-01)

Low-liver-accumulation lipid nanoparticles enhance the efficacy and safety of HPV therapeutic tumor vaccines
by: Xiaodie Wang, et al.
Published: (2025-08-01)

Nanocarriers for inhaled delivery of RNA therapeutics
by: Sebastian G. Huayamares, et al.
Published: (2024-01-01)

Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity
by: Liusheng Wu, et al.
Published: (2024-02-01)

Microfluidic Optimization of PEI-Lipid Hybrid Nanoparticles for Efficient DNA Delivery and Transgene Expression
by: Mahboubeh Hosseini-Kharat, et al.
Published: (2025-04-01)

Research Progress in mRNA Cancer Vaccines: Immunogenicity Regulation, Optimization of Lipid Nanoparticle Delivery Systems, and Challenges in Non-Hepatic Targeting
by: Cheng Zeqing
Published: (2026-01-01)

Intravenous Administration of sRNA Nanoparticles for Treatment of Osteoporosis in Mice
by: Xuemeng Mu, et al.
Published: (2025-06-01)

Inhaled Ivermectin-Loaded Lipid Polymer Hybrid Nanoparticles: Development and Characterization
by: Seyedeh Negin Kassaee, et al.
Published: (2024-08-01)

Exploring the Challenges of Lipid Nanoparticle Development: The In Vitro–In Vivo Correlation Gap
by: Sarah Lindsay, et al.
Published: (2025-03-01)

Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach
by: Rachel E. Young, et al.
Published: (2024-04-01)

Lipid-mRNA nanoparticles landscape for cancer therapy
by: Yin Li, et al.
Published: (2022-10-01)

Industrial Perspective on the Manufacturing of Lipid Nanoparticles for Nucleic Acid Delivery
by: Jenny Hong Hoang, et al.
Published: (2026-04-01)

Thioester-Containing Ionizable Lipids with Enhanced Endosomal Escape and Biodegradability for mRNA and tRNA Delivery
by: Álvaro Peña, et al.
Published: (2026-04-01)

Artificial Intelligence-Driven Strategies for Targeted Delivery and Enhanced Stability of RNA-Based Lipid Nanoparticle Cancer Vaccines
by: Ripesh Bhujel, et al.
Published: (2025-07-01)

State-of-the-Art Review on Inhalable Lipid and Polymer Nanocarriers: Design and Development Perspectives
by: Gabriella Costabile, et al.
Published: (2024-03-01)

Lipid nanoparticle-based mRNA delivery systems for cancer immunotherapy
by: Jieun Han, et al.
Published: (2023-08-01)

Molecular Dynamics Simulation of Lipid Nanoparticles Encapsulating mRNA
by: Zhigang Zhang, et al.
Published: (2024-09-01)

Enhancing Vaccine Efficacy and Stability: A Review of the Utilization of Nanoparticles in mRNA Vaccines
by: Nargish Parvin, et al.
Published: (2024-08-01)

Lipid Nanoparticles Outperform Electroporation in Delivering Therapeutic HPV DNA Vaccines
by: Mingzhu Li, et al.
Published: (2024-06-01)

Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy
by: Min-Hsuan Lin, et al.
Published: (2025-03-01)

Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism
by: Mahboubeh Hosseini-Kharat, et al.
Published: (2025-03-01)

Next-Generation mRNA Vaccines in Melanoma: Advances in Delivery and Combination Strategies
by: Stefano Zoroddu, et al.
Published: (2025-09-01)

Inhalable Nanotechnology-Based Drug Delivery Systems for the Treatment of Inflammatory Lung Diseases
by: Doaa Elsayed Mahmoud, et al.
Published: (2025-07-01)

Inhalable Polymeric Nanoparticles for Pulmonary Delivery of Antimicrobial Peptide SET-M33: Antibacterial Activity and Toxicity In Vitro and In Vivo
by: Laura Cresti, et al.
Published: (2022-12-01)

Lipid Nanoparticle-Mediated RNAi Against GIPC1 Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma
by: Vijay Sagar Madamsetty, et al.
Published: (2025-10-01)

Lipid-Based Inhalable Micro- and Nanocarriers of Active Agents for Treating Non-Small-Cell Lung Cancer
by: Sona Gandhi, et al.
Published: (2023-05-01)

Freeze-Drying of mRNA-LNPs Vaccines: A Review
by: MD Faizul Hussain Khan, et al.
Published: (2025-08-01)

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection
by: Basanth Babu Eedara, et al.
Published: (2021-07-01)

A Pilot Study Exploiting the Industrialization Potential of Solid Lipid Nanoparticle-Based Metered-Dose Inhalers
by: Lei Shu, et al.
Published: (2023-03-01)

Advances in the Development of Lipid Nanoparticles for mRNA Delivery
by: Xing Wang, et al.
Published: (2026-02-01)

Immunogenic and Protective Properties of mRNA Vaccine Encoding Hemagglutinin of Avian Influenza A/H5N8 Virus, Delivered by Lipid Nanoparticles and Needle-Free Jet Injection
by: Vladimir A. Yakovlev, et al.
Published: (2025-08-01)

Aerosol Inhalation Delivery of Ag Nanoparticles in Mice: Pharmacokinetics and Antibacterial Action
by: Sergey V. Valiulin, et al.
Published: (2023-10-01)

Engineering Lipid Nanoparticles to Enhance Intracellular Delivery of Transforming Growth Factor-Beta siRNA (siTGF-β1) via Inhalation for Improving Pulmonary Fibrosis Post-Bleomycin Challenge
by: Xu Deng, et al.
Published: (2025-01-01)

Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy
by: Christoph Wilhelmy, et al.
Published: (2023-08-01)

Nanoplatform-Based Delivery Systems for Enhanced Stability and Efficacy of Nucleic Acid Vaccines
by: Sohameh Mohebbi, et al.
Published: (2025-06-01)

A novel auto-fluorescent porphyrin-lipid nanoparticle strategy for CTNNB1 gene silencing in hepatocellular carcinoma
by: Jeffrey C. To, et al.
Published: (2026-05-01)

An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension
by: Vinit Agnihotri, et al.
Published: (2022-05-01)

An Overview on Spray-Drying of Protein-Loaded Polymeric Nanoparticles for Dry Powder Inhalation
by: Tânia Marante, et al.
Published: (2020-10-01)

Advances in RNA-Based Therapeutics: Challenges and Innovations in RNA Delivery Systems
by: Yuxuan Liu, et al.
Published: (2024-12-01)

Inhalation of nanoparticle-based drug for lung cancer treatment: Advantages and challenges
by: Wing-Hin Lee, et al.
Published: (2015-12-01)